We should be so much better than this.
Post-stroke treatment neglects the most effective – and cost-effective – options. Patients, the health system and the whole economy pay the price.
Most people who have a stroke do not die. Not right away,
anyway.
After 28 days, 80% of people having a first-ever stroke are
still alive. By 12 months, the figure drops to 63%. And for those who survive
that long, the chances of having a second stroke within five years are one in
six.
The declining death rate from stroke – it’s now less than
half the rate of 40 years ago – follows the general decline in general
cardiovascular mortality. There are many factors in this, in both prevention
and treatment. The strong decline in stroke deaths in the 1980s coincided with
the introduction of statins to treat excess cholesterol and the widespread
availability of screening blood tests. (The tick-up in cardiovascular deaths
from 2019 is the result of COVID-19).
But although the death rates are going down, the number of
cases is rising – partly due to the ageing of the population. Over the 20 years
to 2021, the number of people having strokes in a given year increased by 25%.
Because more people now survive their stroke, the number
living with the after-effects has risen substantially. The need – not only for
acute treatment but also for rehabilitation and long-term support – is now much
greater than it was two, three or four decades ago. But our health system has
not kept pace. The emphasis has been on acute care, rather than on the
longer-term care that is disproportionately needed in stroke patients. More
people are being treated more quickly and effectively, with antithrombotic
drugs administered soon after an attack, and treatment in specialist
multidisciplinary stroke units.
But there is still a long way to go. According to the Stroke
Foundation:
- Less than half of stroke patients spent the majority of their acute hospital stay in a stroke unit;
- Only 38% of stroke patients presented to the hospital within the 4.5-hour window for thrombolysis (clot-busting) treatment;
- Australian stroke patients received less timely thrombolysis than patients in the US and Britain.
Rehabilitation: the
greatest neglect
The acute phase, however critical, is only the beginning of
the difficult pathway for stroke patients. The shortcomings in rehabilitation
and long-term support are also in urgent need of attention.
This table shows how different stroke is from most other
conditions in terms of long-term needs. Measuring the burden of disease
calculates the loss to patients from premature death as well as from
disability. Usually, more than half of disease burden comes from death. But in
stroke, by far the greatest loss comes from long-term disability.
In 2009, when the Australian Institute of Health and Welfare
surveyed the area, an estimated 131,000
people were living with disability as a result of stroke. That represents about
one-third of all people who have ever had a stroke. And although older people
were more likely to be affected, the numbers among people under 65 (36,000) are
considerable.
Most of those with long-term disabilities experience more
than one problem. It’s easy to understand, for instance, why someone with
significant physical limitations might also develop psychological symptoms. In
2009, 131,000 individuals accounted for 400,000 separate disabilities.
All of this indicates the critical need for
multidisciplinary rehabilitation teams comprising a range of fields including
physicians, specialist nurses, physiotherapists, occupational therapists,
speech therapists and psychologists. But nowhere in Australia has anywhere near
enough capacity to deliver the extent and intensity of care that stroke
patients urgently need. Only Queensland comes close. The laggard is Tasmania,
where the rate of public hospital rehabilitation treatments is only a third of
even the inadequate national average.
Official guidelines in the US and Britain
specify that people recovering from stroke need an intensive multidisciplinary
therapy program consisting of at least 3 hours a day 5 days per week.
“Stroke rehabilitation is the lifeline of hope for
survivors, their caregivers, and their communities in the days, months, and
years after stroke” says the American clinical position statement. “It is
imperative that governments and other funding agencies balance the support
needed for acute stroke and stroke rehabilitation treatment.”
Though people can benefit from rehabilitation therapy at any
time, most improvement takes place within the first six months after a stroke.
It is therefore crucial that treatment facilities should be available for
everyone who needs them during this critical period. In Australia, that is
clearly not the case. Tasmania, by far the least capable state, is well behind
even the inadequate national average.
As this table shows, care is available in Tasmanian public
hospitals at a fraction of the rate delivered in the rest of the country. The
only significant category in which Tasmania’s figure is higher is for “clinical
assessment only” – that is, where a doctor assesses a patient’s needs but
nothing else happens.
This is how it compares to the rest of the country. On a
population-adjusted basis, New South Wales has an even worse result that
Tasmania.
The need for post-stroke care does not coincide with its
availability. The Australian Institute of Health and Welfare has issued the
first estimates of the number of people experiencing a stroke, by state.
Tasmania, with by far the lowest rate of rehabilitation care, has
proportionally the greatest number needing that care.
Nor does stroke occur evenly across the population: it is
strongly correlated with relative poverty. People with lower incomes tend to
have greater levels of risk factors: obesity, smoking, high blood pressure,
high cholesterol levels.
Despite that need, people in the lower socio-economic
quintiles do not have proportionately greater access hospital care. The richest
20%, who can afford private care, have a relatively much higher rate. But with
cash-strapped private hospitals walking away from rehabilitation, which doesn’t
bring in enough money, it’s uncertain how long that option will last.
It makes little sense to scrimp on stroke rehabilitation,
which is a relatively cheap option. Adequate rehabilitation can avoid much
greater subsequent costs to the health system from further strokes, hospital
readmission and community care. Public hospitals account for three quarters of
all the health system costs of stroke treatment.
This is reflected in economic evidence, which shows massive
savings – to the health system, to patients, their carers and the community. Intensive
rehabilitation is more
effective and more cost-effective that less-intensive interventions.
Multi-disciplinary treatment is more
cost-effective than lower-standard care.
A recent Australian cost-effectiveness
study, published in the British Medical Journal, found that every dollar spent
on rehabilitation for acquired brain injury – which includes stroke – resulted
in a benefit of $92.
Into a black hole
The longer-term prospects for people dealing with the
disabilities of stroke are even less inspiring. Associate Professor Kate
Scrivener, a Melbourne-based clinician and researcher, and three other leading
Australian practitioners in stroke rehabilitation wrote
in the Medical Journal of Australia that long-term survivors have “fallen into
a black hole”.
![]() |
Scrivener ... 'recognise the realities' |
“Recent moves towards early discharge and rehabilitation in
the home have been shown to be less effective in maximising function than
inpatient rehabilitation, whereas functional gain is possible with investment
in subacute and community rehabilitation. After hospitalisation, 64% of people
after stroke are referred for community rehabilitation; however, the actual amount
of community rehabilitation that occurs is profoundly low.”
The failure to provide adequate treatment, both at the acute
and rehabilitation stages, ensures a large and avoidable cohort of people with
disabilities that demand – but often don’t get – life-long care. That
responsibility falls mainly on patients’ partners, parents and children.
The National Disability Insurance Scheme is not of much
help. “In 2020,” the researchers wrote, “the NDIS supported 5,160 people who
nominated stroke as their primary disability — approximately 1% of people after
stroke living in Australia at that time.”
Stroke survivors do not usually qualify for the NDIS if
their disability first occurred after the age of 65. That immediately disqualifies
three-quarters of potential beneficiaries. Other restrictions, which fail to
recognise the realities of post-stroke disability, made the NDIS all but
irrelevant for stroke survivors and their carers.
“It’s time,” the Melbourne researchers wrote, “for people
with long-term disability to have access to the services they need, when they
require them.”
Under the present, fragmented system, no authority has overall responsibility for ensuring a more humane and, in the long run, cheaper – approach. Without a national effort, led by the federal government, nothing much is likely to change. But, as with so much in health policy, that national leadership is missing.